Document is current
Any future updates will be listed below
-
Authors
Podar, Klaus https://orcid.org/0000-0002-7414-3632
-
Funding
Funding for this research was provided by:
Technopol (K3-F-730/003-2020)
Karl Landsteiner Privatuniversität für Gesundheitswissenschaften
- License Information
-
More Information
Article History
Received: 20 February 2025
Accepted: 24 March 2025
First Online: 16 April 2025
Conflict of interest
: K. Podar has received speaker’s honoraria from Celgene, Amgen Inc., and Janssen Pharmaceuticals, consultancy fees from Celgene, Takeda, Sanofi and Janssen Pharmaceuticals, and research support from Roche Pharmaceuticals. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
